KALYDECO Trademark

Trademark Overview

On Saturday, March 31, 2012, a trademark application was filed for KALYDECO with the United States Patent and Trademark Office. The USPTO has given the KALYDECO trademark a serial number of 85585659. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, April 2, 2022. This trademark is owned by Vertex Pharmaceuticals Incorporated. The KALYDECO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cystic fibrosis
kalydeco

General Information

Serial Number85585659
Word MarkKALYDECO
Filing DateSaturday, March 31, 2012
Status800 - REGISTERED AND RENEWED
Status DateSaturday, April 2, 2022
Registration Number4245428
Registration DateTuesday, November 20, 2012
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 4, 2012

Trademark Statements

Description of MarkThe mark consists of a swoosh interrupted by seven dots above the word "KALYDECO".
Goods and ServicesPharmaceutical preparations for the treatment of cystic fibrosis
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 9, 2012
Primary Code005
First Use Anywhere DateWednesday, February 1, 2012
First Use In Commerce DateWednesday, February 1, 2012

Trademark Owner History

Party NameVertex Pharmaceuticals Incorporated
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameVertex Pharmaceuticals Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameVertex Pharmaceuticals Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Saturday, April 2, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Saturday, April 2, 2022REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, April 2, 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, April 2, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, December 3, 2021TEAS SECTION 8 & 9 RECEIVED
Saturday, November 20, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, February 10, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 18, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, December 18, 2017REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, December 18, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, November 21, 2017TEAS SECTION 8 & 15 RECEIVED
Monday, November 20, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, January 14, 2014APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 14, 2014TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 20, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, September 4, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 4, 2012PUBLISHED FOR OPPOSITION
Wednesday, August 15, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 1, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, July 30, 2012ASSIGNED TO LIE
Sunday, July 15, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 12, 2012EXAMINER'S AMENDMENT ENTERED
Thursday, July 12, 2012NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, July 12, 2012EXAMINERS AMENDMENT E-MAILED
Thursday, July 12, 2012EXAMINERS AMENDMENT -WRITTEN
Thursday, July 12, 2012ASSIGNED TO EXAMINER
Tuesday, April 10, 2012NOTICE OF DESIGN SEARCH CODE MAILED
Monday, April 9, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 4, 2012NEW APPLICATION ENTERED

Related Keywords

kalydeco fibrosis cystic treatment preparations pharmaceutical